PL366232A1 - Protease inhibitors - Google Patents
Protease inhibitorsInfo
- Publication number
- PL366232A1 PL366232A1 PL01366232A PL36623201A PL366232A1 PL 366232 A1 PL366232 A1 PL 366232A1 PL 01366232 A PL01366232 A PL 01366232A PL 36623201 A PL36623201 A PL 36623201A PL 366232 A1 PL366232 A1 PL 366232A1
- Authority
- PL
- Poland
- Prior art keywords
- protease inhibitors
- protease
- inhibitors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US25250800P | 2000-11-22 | 2000-11-22 | |
| PCT/US2001/051647 WO2003053331A2 (en) | 2000-11-22 | 2001-11-19 | Protease inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL366232A1 true PL366232A1 (en) | 2005-01-24 |
Family
ID=22956303
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL01366232A PL366232A1 (en) | 2000-11-22 | 2001-11-19 | Protease inhibitors |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP1392657A4 (pt) |
| JP (1) | JP2005513083A (pt) |
| KR (1) | KR20040004445A (pt) |
| CN (1) | CN1635903A (pt) |
| AR (1) | AR034278A1 (pt) |
| AU (1) | AU2001298052A1 (pt) |
| BR (1) | BR0115473A (pt) |
| CA (1) | CA2436850A1 (pt) |
| CZ (1) | CZ20031403A3 (pt) |
| HU (1) | HUP0301964A3 (pt) |
| IL (1) | IL155997A0 (pt) |
| MX (1) | MXPA03004542A (pt) |
| NO (1) | NO20032328L (pt) |
| PL (1) | PL366232A1 (pt) |
| UY (1) | UY27032A1 (pt) |
| WO (1) | WO2003053331A2 (pt) |
| ZA (1) | ZA200303848B (pt) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030144175A1 (en) | 1998-12-23 | 2003-07-31 | Smithkline Beecham Corporation | Protease inhibitors |
| CN1416346A (zh) | 2000-03-21 | 2003-05-07 | 史密丝克莱恩比彻姆公司 | 蛋白酶抑制剂 |
| AU2001268407A1 (en) * | 2000-06-14 | 2001-12-24 | Smithkline Beecham Corporation | Protease inhibitors |
| CN101970007A (zh) | 2007-06-08 | 2011-02-09 | 日本化学医药株式会社 | 脑动脉瘤的治疗或预防药 |
| JPWO2009054454A1 (ja) | 2007-10-24 | 2011-03-03 | 国立大学法人 東京医科歯科大学 | カテプシン阻害剤を有効成分として含有するＴｏｌｌ様受容体のシグナル伝達の調整剤 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ511710A (en) * | 1998-12-23 | 2003-12-19 | Smithkline Beecham Corp | 4-Amino-azepan-3-one derivatives useful as protease inhibitors |
| CN1416346A (zh) * | 2000-03-21 | 2003-05-07 | 史密丝克莱恩比彻姆公司 | 蛋白酶抑制剂 |
| AU2001268407A1 (en) * | 2000-06-14 | 2001-12-24 | Smithkline Beecham Corporation | Protease inhibitors |
-
2001
- 2001-11-19 CN CNA018220533A patent/CN1635903A/zh active Pending
- 2001-11-19 AU AU2001298052A patent/AU2001298052A1/en not_active Abandoned
- 2001-11-19 JP JP2003554091A patent/JP2005513083A/ja not_active Withdrawn
- 2001-11-19 HU HU0301964A patent/HUP0301964A3/hu unknown
- 2001-11-19 CA CA002436850A patent/CA2436850A1/en not_active Abandoned
- 2001-11-19 MX MXPA03004542A patent/MXPA03004542A/es unknown
- 2001-11-19 WO PCT/US2001/051647 patent/WO2003053331A2/en not_active Application Discontinuation
- 2001-11-19 CZ CZ20031403A patent/CZ20031403A3/cs unknown
- 2001-11-19 IL IL15599701A patent/IL155997A0/xx unknown
- 2001-11-19 EP EP01275089A patent/EP1392657A4/en not_active Withdrawn
- 2001-11-19 PL PL01366232A patent/PL366232A1/xx not_active Application Discontinuation
- 2001-11-19 BR BR0115473-7A patent/BR0115473A/pt not_active Application Discontinuation
- 2001-11-19 KR KR10-2003-7006807A patent/KR20040004445A/ko not_active Application Discontinuation
- 2001-11-20 AR ARP010105409A patent/AR034278A1/es unknown
- 2001-11-21 UY UY27032A patent/UY27032A1/es not_active Application Discontinuation
-
2003
- 2003-05-16 ZA ZA200303848A patent/ZA200303848B/en unknown
- 2003-05-22 NO NO20032328A patent/NO20032328L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CZ20031403A3 (cs) | 2003-10-15 |
| UY27032A1 (es) | 2002-07-31 |
| WO2003053331A3 (en) | 2003-11-13 |
| MXPA03004542A (es) | 2003-09-10 |
| JP2005513083A (ja) | 2005-05-12 |
| EP1392657A2 (en) | 2004-03-03 |
| WO2003053331A2 (en) | 2003-07-03 |
| HUP0301964A2 (en) | 2007-02-28 |
| CN1635903A (zh) | 2005-07-06 |
| EP1392657A4 (en) | 2004-03-10 |
| NO20032328L (no) | 2003-07-02 |
| KR20040004445A (ko) | 2004-01-13 |
| AU2001298052A1 (en) | 2003-07-09 |
| IL155997A0 (en) | 2003-12-23 |
| CA2436850A1 (en) | 2003-07-03 |
| NO20032328D0 (no) | 2003-05-22 |
| BR0115473A (pt) | 2004-09-28 |
| ZA200303848B (en) | 2004-06-28 |
| AR034278A1 (es) | 2004-02-18 |
| HUP0301964A3 (en) | 2007-09-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU4344101A (en) | Protease inhibitors | |
| GB0125445D0 (en) | Protease Inhibitors | |
| IL215890A0 (en) | Peptidomimetic protease inhibitors | |
| IL153421A0 (en) | Protease inhibitors | |
| EP1235577A4 (en) | PROTEASE INHIBITORS | |
| EP1232155A4 (en) | PROTEASE INHIBITORS | |
| IL151087A0 (en) | Protease inhibitors | |
| EP1231921A4 (en) | PROTEASE INHIBITORS | |
| EP1229912A4 (en) | PROTEASE INHIBITORS | |
| EP1229914A4 (en) | PROTEASE INHIBITORS | |
| EP1229915A4 (en) | PROTEASE INHIBITORS | |
| EP1161237A4 (en) | PROTEASE INHIBITORS | |
| EP1229911A4 (en) | PROTEASE INHIBITORS | |
| EP1173429A4 (en) | PROTEASE INHIBITORS | |
| EP1351930A4 (en) | PROTEASE INHIBITORS | |
| EP1233771A4 (en) | PROTEASE INHIBITORS | |
| EP1401453A4 (en) | PROTEASE INHIBITORS | |
| EP1231923A4 (en) | PROTEASE INHIBITORS | |
| HUP0301964A3 (en) | Protease inhibitors | |
| IL155961A0 (en) | Cysteine protease inhibitors | |
| EP1231922A4 (en) | PROTEASE INHIBITORS | |
| EP1232154A4 (en) | PROTEASE INHIBITORS | |
| AU6407701A (en) | Serine protease inhibitors | |
| GB0009123D0 (en) | Protease inhibitor | |
| ZA200207478B (en) | Protease inhibitors. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| REFS | Decisions on refusal to grant patents (taken after the publication of the particulars of the applications) |